Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Drops By 47.2%

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 30,900 shares, a decrease of 47.2% from the September 30th total of 58,500 shares. Based on an average daily volume of 24,100 shares, the short-interest ratio is currently 1.3 days.

PURE Bioscience Trading Up 24.6 %

PURE Bioscience stock traded up $0.02 during mid-day trading on Friday, hitting $0.10. The stock had a trading volume of 31,138 shares, compared to its average volume of 27,896. The stock has a 50-day simple moving average of $0.07 and a two-hundred day simple moving average of $0.07. The stock has a market capitalization of $11.15 million, a PE ratio of -1.66 and a beta of 0.07. PURE Bioscience has a 12 month low of $0.06 and a 12 month high of $0.17.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.